Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | APP | P05067 | 4/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | RBP4 | P02753 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.80 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.80 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | DRD3 | P35462 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Retinol SCHEMBL1433566 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL3112 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL15593 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL19660979 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL17226 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL8360234 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL3113 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL14619410 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL15592 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL1580302 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569629-A | Method for reducing yellow chromaticity of vitamin A acetate | 万华化学集团股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119462461-A | Method for isomerizing vitamin A | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119176771-B | Preparation method of vitamin A palmitate 3 cis-isomer impurity reference substances | 济南康和医药科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119176771-A | Preparation method of vitamin A palmitate 3 cis-isomer impurity reference substances | 济南康和医药科技有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-114367253-B | Optical channel reactor and preparation method of high-purity all-trans vitamin A acetate and derivative crystal thereof | 万华化学集团股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-114367253-A | Optical channel reactor and preparation method of high-purity all-trans vitamin A acetate and derivative crystal thereof | 万华化学集团股份有限公司 | 2022-04-19 | — | — | CN | claimed |
| US-20260102361-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING ISOTRETINOIN AND PROCESSES FOR PREPARATION AND USES THEREOF | Acrotech Biopharma Inc. (US) | 2026-04-16 | — | — | US | disclosed |
| US-12527750-B2 | Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof | Acrotech Biopharma Inc. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | disclosed |
| CN-119462461-B | Method for isomerizing vitamin A | 万华化学集团股份有限公司 | 2025-11-04 | — | — | CN | disclosed |
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-09-25 | — | — | US | disclosed |
| EP-4577516-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577517-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-2334782-B1 | NON-PHOTOSYNTHETIC MICRO-ORGANISMS ENRICHED WITH ORGANIC SELENIUM FROM SELENO-HYDROXYACID COMPOUNDS, AND APPLICATIONS THEREOF IN THE FIELDS OF NUTRITION AND COSMETICS | TETRAHEDRON (FR) | 2014-07-09 | — | — | EP | disclosed |
| US-8535931-B2 | Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds and applications thereof in the field of nutrition, cosmetics and pharmacueuticals | TETRAHEDRON (FR) | 2013-09-17 | — | — | US | disclosed |
| WO-2010023291-A1 | NON-PHOTOSYNTHETIC MICRO-ORGANISMS ENRICHED WITH ORGANIC SELENIUM FROM SELENO-HYDROXYACID COMPOUNDS, AND APPLICATIONS THEREOF IN THE FIELDS OF NUTRITION, COSMETICS, AND PHARMACEUTICALS | TETRAHEDRON (FR) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010023384-A1 | PHOTOSYNTHETIC MICROORGANISMS ENRICHED IN SELENIUM USING SELENOHYDROXY ACID COMPOUNDS, USES THEREOF IN NUTRITION, COSMETICS AND PHARMACY | ECO SOLUTION (FR) | 2010-03-04 | — | — | WO | disclosed |
| EP-1778706-B1 | NEW SELENOHYDROXY ACIDS AND THEIR DERIVATIVES: APPLICATIONS IN NUTRITION, COSMETICS AND PHARMACEUTICS | TETRAHEDRON (FR) | 2009-07-08 | — | — | EP | disclosed |
| US-7381416-B2 | Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | TETRAHEDRON SAS (FR) | 2008-06-03 | — | — | US | disclosed |
| US-7381416-B2 | Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | TETRAHEDRON SAS (FR) | 2008-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | ALDH1A2, ADH4, RBP4 | ALDH1A1 21/4885MAPT 4478/4885CYP3A4 175/4885 |
| US-20260102361-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING ISOTRETINOIN AND PROCESSES FOR PREPARATION AND USES THEREOF | RARA, RARB, RARG | ALDH1A1 741/4885MAPT 4322/4885CYP3A4 802/4885 |
| US-12527750-B2 | Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof | STRA6, LRAT, DGAT2 | ALDH1A1 1264/4885MAPT 728/4885CYP3A4 963/4885 |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | ALDH1A1 4219/4885MAPT 411/4885CYP3A4 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.